Company: SXTPW
Filing Date: 2025-07-16
Form Type: 424B4
Source: 0001213900-25-064472
Chunk: 51

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-07-16
Form: 424B4
Chunk 51
---
 offering, no exercise of the Series A-1 Warrants and Series A-2 Warrants being   
 offered in this offering and no value being attributed to the Warrants.                                                                      |

You should read the following table in conjunction
with the section titled “Use of Proceeds” in this prospectus and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” as well as our financial statements and related notes appearing in our Annual
Report on Form 10-K for the year ended December 31, 2024 and our Quarterly Report on Form 10-Q for the three months ended March 31, 2025,
which are incorporated by reference in this prospectus.

The information set forth below is illustrative
only and will be adjusted based on the actual public offering price and other terms of this offering determined at pricing.

|                                                                                                                                                                                                           |     | Actual |             |   |     | As          
 Adjusted(1) |             |   |
|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|:----|:-------|------------:|:--|:----|:------------|------------:|:--|
| Cash, cash equivalents and short-term investments                                                                                                                                                         |     | $      |   3,451,500 |   |     | $           |   7,632,011 |   |
| Total long-term liabilities                                                                                                                                                                               |     | $      |     146,502 |   |     | $           |     146,502 |   |
| Series A Preferred Stock, $0.0001 par value, 1,000,000 shares authorized; 76,480 issued and outstanding as of March 31, 2025, actual, 76,480 issued and outstanding, as adjusted                          |     | $      |   9,567,439 |   |     | $           |   9,567,439 |   |
| Common stock, $0.0001 par value; 150,000,000 shares authorized at March 31, 2025; 1,472,891 shares issued and outstanding at March 31, 2025, actual; 4,104,469 shares issued and outstanding, as adjusted |     | $      |         147 |   |     | $           |         410 |   |
| Additional paid-in capital                                                                                                                                                                                |     | $      |  36,821,588 |   |     | $           |  41,001,836 |   |
|